Edition:
United States

Agilent Technologies Inc (A)

A on New York Consolidated

53.50USD
23 Mar 2017
Change (% chg)

$0.37 (+0.70%)
Prev Close
$53.13
Open
$53.04
Day's High
$53.63
Day's Low
$52.72
Volume
665,721
Avg. Vol
2,052,908
52-wk High
$54.82
52-wk Low
$38.89

Latest Key Developments (Source: Significant Developments)

Agilent Technologies' CEO Michael Mcmullen 2016 total compensation was $8.9 mln vs. $7.2 mln in 2015 - SEC Filing
Thursday, 2 Feb 2017 04:35pm EST 

Agilent Technologies Inc :Agilent Technologies Inc - CEO Michael R. Mcmullen 2016 total compensation was $8.9 million versus $7.2 million in 2015 - SEC Filing.  Full Article

Agilent Technologies to acquire Multiplicom N.V.
Tuesday, 20 Dec 2016 04:05pm EST 

Agilent Technologies Inc : Agilent Technologies Inc - Agilent is acquiring Multiplicom for approximately EUR68 million in cash . Agilent Technologies Inc - acquisition is expected to be completed by mid-January . Agilent Technologies to acquire Multiplicom N.V., a leading European diagnostics company with state-of-the-art genetic testing technology and products .Agilent Technologies to acquire Multiplicom N.V., a leading European diagnostics company with state-of-the-art genetic testing technology and products.  Full Article

Agilent Technologies increases cash dividend to 13.2 cents per share
Thursday, 17 Nov 2016 06:04pm EST 

Agilent Technologies Inc - : Sets quarterly dividend of $0.132 per share .Agilent Technologies increases cash dividend to 13.2 cents per share.  Full Article

Agilent Technologies reports fourth-quarter 2016 results
Tuesday, 15 Nov 2016 04:05pm EST 

Agilent Technologies Inc : Agilent Technologies reports fourth-quarter 2016 results . Fy2017 revenue view $4.35 billion -- Thomson Reuters I/B/E/S . Q1 earnings per share view $0.53 -- Thomson Reuters I/B/E/S . Fy2017 earnings per share view $2.19 -- Thomson Reuters I/B/E/S . Q4 non-GAAP earnings per share $0.59 from continuing operations . Sees Q1 2017 revenue $1.04 billion to $1.06 billion . Q4 revenue $1.11 billion versus I/B/E/S view $1.07 billion . Sees Q1 2017 non-GAAP earnings per share $0.48 to $0.50 . Sees FY 2017 non-GAAP earnings per share $2.10 to $2.16 . Q4 GAAP earnings per share $0.38 from continuing operations . Sees fy 2017 revenue $4.35 billion to $4.37 billion .Q4 earnings per share view $0.52 -- Thomson Reuters I/B/E/S.  Full Article

Agilent Technologies, Burning Rock sign agreement on molecular diagnostics
Thursday, 29 Sep 2016 12:00am EDT 

Agilent Technologies Inc : Says Agilent Technologies and Burning Rock sign agreement on molecular diagnostics .Says Burning Rock plans to register its molecular diagnostic kit with China Food And Drug Administration.  Full Article

Agilent Tech sees FY 2016 non-gaap earnings per share $1.89 to $1.91
Wednesday, 17 Aug 2016 04:05pm EDT 

Agilent Technologies Reports Third : Quarter 2016 results . Sees q4 non-gaap earnings per share $0.50 to $0.52 . Q3 non-gaap earnings per share $0.49 from continuing operations . Sees q4 2016 revenue $1.05 billion to $1.07 billion . Sees fy 2016 non-gaap earnings per share $1.89 to $1.91 . Q3 gaap earnings per share $0.38 from continuing operations . Sees fy 2016 revenue $4.14 billion to $4.16 billion . Q3 earnings per share view $0.47 -- Thomson Reuters I/B/E/S . Q3 earnings per share view $0.47, revenue view $1.05 billion -- Thomson Reuters I/B/E/S . Q4 earnings per share view $0.54, revenue view $1.09 billion -- Thomson Reuters I/B/E/S .Fy2016 earnings per share view $1.91, revenue view $4.18 billion -- Thomson Reuters I/B/E/S.  Full Article

Agilent Technologies to build new facility in Colorado
Tuesday, 9 Aug 2016 08:00pm EDT 

Agilent Technologies Inc : Agilent technologies to build new facility in Colorado, increasing pharmaceutical manufacturing capacity . Expansion to enable co to more than double its commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients Further company coverage: [A.N] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Agilent Technologies posts adj profit of $0.44 from cont ops
Monday, 16 May 2016 04:05pm EDT 

Agilent Technologies : Raises its full-year operating cash flow guidance from $650 million to $740 million . Raises FY guidance for core revenue growth , adjusted non-GAAP operating margin , non-GAAP earnings per share, operating cash flow . No change to FY capital expenditure guidance of $140 million . Q2 net revenue $1,019 million . Q3 earnings per share view $0.47, revenue view $1.04 billion -- Thomson Reuters I/B/E/S . Fy2016 earnings per share view $1.86, revenue view $4.13 billion -- Thomson Reuters I/B/E/S . Quarter 2016 results . Sees Q3 non-GAAP earnings per share $0.45 to $0.47 . Sees FY 2016 non-GAAP earnings per share $1.88 to $1.92 . Q2 non-GAAP earnings per share $0.44 from continuing operations . Q2 GAAP earnings per share $0.28 from continuing operations . Sees Q3 2016 revenue $1.03 billion to $1.05 billion . Sees FY 2016 revenue $4.16 billion to $4.18 billion .Q2 earnings per share view $0.39 -- Thomson Reuters I/B/E/S.  Full Article

Enzo Biochem Inc reaches $9 million patent infringement settlement with Agilent Technologies Inc
Wednesday, 6 Jan 2016 08:30am EST 

Enzo Biochem Inc:Has reached and finalized a settlement with Agilent Technologies Inc payment of $9 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197.Says resolved suit involves one of 11 infringement cases brought in delaware federal district court, eight of which remain pending.  Full Article

Protea Biosciences Group, Inc announces Biopharm Industry Collaboration
Tuesday, 8 Dec 2015 08:00am EST 

Protea Biosciences Group, Inc:Says it is collaborating with Agilent Technologies, Inc to address customer challenges within existing Biopharma bioanalytical workflows in order to meet the emerging needs of the growing biopharmaceutical industry.Memorandum of Understanding (MOU), Protea, using Agilent instrumentation combined with its technology, will develop workflows that focus on developing new methods for the field of metabolomics.  Full Article

More From Around the Web

BRIEF-Agilent Technologies introduces a new target enrichment solution for next-generation DNA sequencing

* Introduced a new target enrichment solution for next-generation DNA sequencing Source text for Eikon: Further company coverage: